|
|
|
| Clinical analysis of outcomes of microwave therapy in treating cervical HPV sub-clinical infections |
| GUO Ying1,YE Qingjian2,LIN Mengyuan2,YANG Yuebo2,and LI Xiaomao2 |
1.Department of Gynecology, Guangzhou iBorn Women’s & Children’s Hospital, Guangzhou 510630,China;
2.Department of Gynecology, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630,China |
|
|
|
|
Abstract Objective To investigate the effectiveness of microwave therapy in clearing HPV infections.Methods One hundred and sixty-five cases of cervical HPV infections were enrolled in this study, who were assigned into treatment group( microwave therapy group; 47 cases), and control group(118 cases). The therapeutic effect on HPV infections was compared between the two groups.Results The median HPV clearance time of the microwave group was 194 days(ranging from 72 to 532 days), while that of the control group was 284 days (ranging from 119 to 777 days). HPV clearance rates of the microwave group and control group were 93.6%(44 cases ) and 77.1%(91 cases)respectively, so the difference was statistically significant (P<0.05).Conclusions The microwave treatment is a safe and reliable approach to cervical HPV sub-clinical infections, which can not only increase the clearance rate, but also reduce the clearance time.
|
|
Received: 28 August 2017
|
|
|
|
|
|
| [1] |
Guan P,Howell-Jones R,Li N,et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer[J]. Int J Cancer,2012,131(10): 2349-2359.
|
| [2] |
Centers for Disease Control and Prevention, Sexually transmitted diseases treatment guidelines[J]. MMWR Recomm Rep, 2015,64(RR-03): 1-137.
|
| [3] |
Kollipara R,Ekhlassi E, Downing C,et al.Advancements in Pharmacotherapy for Noncancerous Manifestations of HPV[J]. J Clin Med, 2015,4(5): 832-846.
|
| [4] |
种树彬,曾 抗,李国锋,等.鬼臼毒素纳米脂质载体的制备及体外对HPV感染的永生化人宫颈上皮细胞的作用[J].南方医科大学学报, 2011,31(6):1023-1028.
|
| [5] |
ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 61, April 2005. Human papillomavirus[J]. Obstet Gynecol, 2005,105(4): 905-918.
|
| [6] |
Lin C T,Qiu J T, Wang C J,et al. Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia[J]. Taiwan J Obstet Gynecol, 2012,51(4): 533-538.
|
| [7] |
李爱禄,贺锦曦,饶靖红,等,重组人干扰素α2b阴道泡腾胶囊治疗宫颈HPV感染64例临床分析[J].实用妇产科杂志,2010,26(5):395-396.
|
| [8] |
付长凤,武秀丽,邢丽颖,等,微波联合保妇康栓治疗CIN Ⅰ合并HPV感染的临床疗效观察[J].肿瘤药学,2012,2(2):145-147.
|
| [9] |
杨菊容.干扰素联合微波治疗宫颈糜烂合并HPV感染的临床观察[J].河北医学,2011,17(1):23-26.
|
| [10] |
商宇红, 白丽霞, 魏丽惠. 中药保妇康栓对宫颈癌细胞抑制作用的分子机制研究[J].中国妇产科临床杂志,2003,4(5): 336-339.
|
| [11] |
Martin-Hirsch P P, Paraskevaidis E, Bryant A, et al. Surgery for cervical intraepithelial neoplasia[J]. Cochrane Database Syst Rev, 2013,12: 1318.
|
| [12] |
唐志英,唐志华.保妇康栓联合微波治疗慢性宫颈炎合并HPV感染的临床观察[J].中国医药指南,2012,09(10):275-276.
|
| [1] |
. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2016, 27(8): 833-833. |
|
|
|
|
2018, Vol. 29 
